Matrix Advisors Value Fund TMO trades
David Katz
David Katz Thermo Fisher Scientific Inc stake
total: 54
Trades details
- Total transactions:
- 8
- New positions:
- 1
- Added:
- 2
- Reduced:
- 5
- Held since:
- 2020 Q1
- Held for:
- 20 quarters
- Latest activity:
- 2023 Q1
According to 2024 Q4 report, David Katz holds 3,000 Thermo Fisher Scientific Inc (TMO) shares with a market value of roughly $1.56M accounting for 2.21% of the overall portfolio. To date, the estimated cost basis is nearly $297.59 for "buy" trades and estimated average "sell" price is $447.53. Matrix Advisors Value Fund first purchased TMO in 2020 Q1, initially acquiring 4,700 shares. Since the initial investment in Thermo Fisher Scientific Inc (TMO), Matrix Advisors Value Fund has made 7 more transactions.
When did David Katz buy Thermo Fisher Scientific Inc (TMO)?
David Katz first invested in Thermo Fisher Scientific Inc (TMO) in 2020 Q1 at the reported quarter-end price of $283.60 per share.
What's the cost basis of Matrix Advisors Value Fund's TMO stake?
The estimated cost basis for Thermo Fisher Scientific Inc (TMO) stake is around $297.59 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $297.59
- Weighted AVG sell price:
- $447.53
David Katz's historical trades in Thermo Fisher Scientific Inc
8 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2023 Q1
|
3.15%
|
3,000
|
$576.37
|
$1,729,110
|
-6.25% (-200)
|
-0.23%
|
|
2022 Q1
|
2.87%
|
3,200
|
$590.65
|
$1,890,080
|
+5.79% (+175)
|
+0.16%
|
|
2021 Q4
|
2.87%
|
3,025
|
$667.24
|
$2,018,401
|
-3.97% (-125)
|
-0.12%
|
|
2021 Q2
|
2.44%
|
3,150
|
$504.47
|
$1,589,080
|
+2.27% (+70)
|
+0.05%
|
|
2020 Q4
|
2.67%
|
$465.78
|
-17.54% (-655)
|
|||
|
2020 Q3
|
3.48%
|
$441.52
|
-5.44% (-215)
|
|||
|
2020 Q2
|
2.97%
|
$362.34
|
-15.96% (-750)
|
|||
|
2020 Q1
|
3.37%
|
$283.60
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.